TLR3 and viral infectious disease: Compound 4a antagonist binds to TLR3/dsRNA to suppress TLR3 activity in gastrointestinal viral infections as well as the expression of downstream TLR3/dsRNA signaling pathways, including TNF-α and IL-1β (45).